» Articles » PMID: 32028670

PPAR-Mediated Toxicology and Applied Pharmacology

Overview
Journal Cells
Publisher MDPI
Date 2020 Feb 8
PMID 32028670
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Peroxisome proliferator-activated receptors (PPARs), members of the nuclear hormone receptor family, attract wide attention as promising therapeutic targets for the treatment of multiple diseases, and their target selective ligands were also intensively developed for pharmacological agents such as the approved drugs fibrates and thiazolidinediones (TZDs). Despite their potent pharmacological activities, PPARs are reported to be involved in agent- and pollutant-induced multiple organ toxicity or protective effects against toxicity. A better understanding of the protective and the detrimental role of PPARs will help to preserve efficacy of the PPAR modulators but diminish adverse effects. The present review summarizes and critiques current findings related to PPAR-mediated types of toxicity and protective effects against toxicity for a systematic understanding of PPARs in toxicology and applied pharmacology.

Citing Articles

Regulatory role of PPAR in colorectal cancer.

Wang C, Lv T, Jin B, Li Y, Fan Z Cell Death Discov. 2025; 11(1):28.

PMID: 39875357 PMC: 11775197. DOI: 10.1038/s41420-025-02313-2.


Contaminant-Associated Disruption of the Skin Transcriptome in the Endangered St. Lawrence Estuary Beluga.

Simond A, Lesage V, Verreault J, Loseto L, Houde M, Elliott A Environ Sci Technol. 2025; 59(5):2389-2399.

PMID: 39874536 PMC: 11823453. DOI: 10.1021/acs.est.4c08272.


How PPAR-alpha mediated inflammation may affect the pathophysiology of chronic kidney disease.

Masenga S, Desta S, Hatcher M, Kirabo A, Lee D Curr Res Physiol. 2024; 8:100133.

PMID: 39665027 PMC: 11629568. DOI: 10.1016/j.crphys.2024.100133.


The Versatile Role of Peroxisome Proliferator-Activated Receptors in Immune-Mediated Intestinal Diseases.

Posta E, Fekete I, Varkonyi I, Zold E, Barta Z Cells. 2024; 13(20.

PMID: 39451206 PMC: 11505700. DOI: 10.3390/cells13201688.


Per- and Polyfluoroalkyl Substances (PFASs) and Their Potential Effects on Female Reproductive Diseases.

Yi Y, Feng Y, Shi Y, Xiao J, Liu M, Wang K Toxics. 2024; 12(8).

PMID: 39195641 PMC: 11358978. DOI: 10.3390/toxics12080539.


References
1.
Stephen R, Gustafsson M, Jarvis M, Tatoud R, Marshall B, Knight D . Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell lines. Cancer Res. 2004; 64(9):3162-70. DOI: 10.1158/0008-5472.can-03-2760. View

2.
Corrales P, Vidal-Puig A, Medina-Gomez G . PPARs and Metabolic Disorders Associated with Challenged Adipose Tissue Plasticity. Int J Mol Sci. 2018; 19(7). PMC: 6073677. DOI: 10.3390/ijms19072124. View

3.
Upham J, Acott P, ORegan P, Sinal C, Crocker J, Geldenhuys L . The pesticide adjuvant, Toximul, alters hepatic metabolism through effects on downstream targets of PPARalpha. Biochim Biophys Acta. 2007; 1772(9):1057-64. DOI: 10.1016/j.bbadis.2007.06.003. View

4.
Mangoni M, Sottili M, Gerini C, Desideri I, Bastida C, Pallotta S . A PPAR-gamma agonist protects from radiation-induced intestinal toxicity. United European Gastroenterol J. 2017; 5(2):218-226. PMC: 5349355. DOI: 10.1177/2050640616640443. View

5.
Da Silva S, Keita A, Mohlin S, Pahlman S, Theodorou V, Pahlman I . A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models. Inflamm Bowel Dis. 2018; 24(4):792-805. DOI: 10.1093/ibd/izx079. View